UnitedHealth Group completed its $3.3 billion purchase of Baton Rouge-based Amedisys Thursday morning, more than two years after plans to join the nation's two largest home health and hospice care companies were first announced.

The closure of the deal was announced in a filing with the U.S. Securities and Exchange Commission, issued before the markets opened. Amedisys stock was delisted from the NASDAQ exchange.

UnitedHealth agreed to buy Amedisys for $101 per share in June 2023. Under the agreement, Amedisys will continue to operate as a wholly-owned subsidiary of UnitedHealth, with an office in Baton Rouge and operations in Nashville, Tennessee.

The deal was set to close in the second half of 2024, but in November, the U.S. Department of Justice sued to block the deal, citing concern

See Full Page